All Stories

  1. A brief survey of cytokine production and blood levels in chronic lymphocytic leukemia (CLL)

    Article • Cancers, September 2020, MDPI AG

    Dr Günter Krause

  2. Commentary about a published BTK inhibitor characterization

    Article • British Journal of Pharmacology, January 2020, Wiley

    Dr Günter Krause

  3. Review article about the PI3K inhibitor copanlisib against B cell malignancies

    Article • Drug Design Development and Therapy, August 2018, Dove Medical Press

    Dr Günter Krause

  4. Impairment of ADCC by kinase inhibitors measured in NK-cell line-based assays

    Article • BioMed Research International, January 2018, Hindawi Publishing Corporation

    Dr Günter Krause, Safi Midda

  5. BTK function in malignant B cells

    Article • British Journal of Haematology, June 2017, Wiley

    Dr Günter Krause

  6. Combinations of BI 836826 that effectively kill CLL cells

    Article • British Journal of Haematology, August 2015, Wiley

    Dr Günter Krause

  7. Inhibitors of PI3K in CLL

    Article • International Journal of Cancer, May 2015, Wiley

    Dr Günter Krause

  8. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor

    Article • Blood, November 2012, American Society of Hematology

    Dr Günter Krause

  9. Total Synthesis of Indole-Derived Allocolchicine Analogues Exhibiting Strong Apoptosis-Inducing Activity

    Article • Chemistry - A European Journal, August 2012, Wiley

    Dr Günter Krause

  10. In Vitro Sensitivity Testing in the Assessment of Anti-CLL Drug Candidates

    Article • February 2012, IntechOpen

    Dr Günter Krause

  11. Comparison of the Effects of Two Kinase Inhibitors, Sorafenib and Dasatinib, on Chronic Lymphocytic Leukemia Cells

    Article • Oncology Research and Treatment, January 2012, Karger Publishers

    Dr Günter Krause

  12. Action of novel CD37 antibodies on chronic lymphocytic leukemia cells

    Article • Leukemia, September 2011, Springer Science + Business Media

    Dr Günter Krause

  13. On the assessment of dasatinib-induced autophagy in CLL

    Article • Leukemia Research, January 2011, Elsevier

    Dr Günter Krause

  14. Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells

    Article • British Journal of Haematology, December 2010, Wiley

    Dr Günter Krause

  15. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

    Article • Blood, August 2009, American Society of Hematology

    Dr Günter Krause

  16. The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes

    Article • Blood, May 2008, American Society of Hematology

    Dr Günter Krause

  17. Role of p21WAF1/CIP1 as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells

    Article • Annals of Hematology, October 2007, Springer Science + Business Media

    Dr Günter Krause

  18. Src family tyrosine kinases phosphorylate Flt3 on juxtamembrane tyrosines and interfere with receptor maturation in a kinase-dependent manner

    Article • Annals of Hematology, August 2007, Springer Science + Business Media

    Dr Günter Krause

  19. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases

    Article • Oncogene, February 2007, Springer Science + Business Media

    Dr Günter Krause

  20. In vitro genotoxicity assay of sidestream smoke using a human bronchial epithelial cell line

    Article • Food and Chemical Toxicology, June 2002, Elsevier

    Dr Günter Krause

  21. Spontaneous and chemically induced point mutations in HPRT cDNA of the metabolically competent human lymphoblastoid cell line, MCL-5

    Article • Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, December 1999, Elsevier

    Dr Günter Krause

  22. Base‐substitution profiles of externally activated polycyclic aromatic hydrocarbons and aromatic amines determined in a lacZ reversion assay

    Article • Environmental and Molecular Mutagenesis, January 1999, Wiley

    Dr Günter Krause

  23. Base-substitution profiles of externally activated polycyclic aromatic hydrocarbons and aromatic amines determined in alacZ reversion assay

    Article • Environmental and Molecular Mutagenesis, January 1999, Wiley

    Dr Günter Krause

  24. Rapid characterization of mutations in amplified human hprt cDNA by polyacrylamide gel electrophoresis

    Article • Mutation Research/Mutation Research Genomics, November 1998, Elsevier

    Dr Günter Krause

  25. Genotyping metabolic polymorphisms in a cohort of Caucasians and single strand conformation polymorphism analysis of point mutations in humanhprt exons 7 and 8

    Article • Electrophoresis, October 1998, Wiley

    Dr Günter Krause

  26. Transcripts encoding three types of guanylyl-cyclase-coupled trans-membrane receptors in inner ear tissues of guinea pigs

    Article • Hearing Research, August 1997, Elsevier

    Dr Günter Krause

  27. Applications of consensus polymerase chain reaction with subsequent electrophoretic distinction of amplificates

    Article • Electrophoresis, January 1997, Wiley

    Dr Günter Krause

  28. Distribution of membrane bound guanylyl cyclases in human intestine.

    Article • Gut, September 1994, BMJ

    Dr Günter Krause

  29. Distinction of weakly homologous cDNA amplificates by single-strand conformation polymorphism analysis: Application to guanylyl cyclase isozymes

    Article • Electrophoresis, January 1994, Wiley

    Dr Günter Krause

  30. Motion of aromatic side chains, picosecond fluorescence, and internal energy transfer in Escherichia coli thioredoxin studied by site-directed mutagenesis, time-resolved fluorescence spectroscopy, and molecular dynamics simulations

    Article • Biochemistry, October 1991, American Chemical Society (ACS)

    Dr Günter Krause

  31. Assignment of the 15 N NMR spectra of reduced and oxidized Escherichia coli thioredoxin

    Article • FEBS Letters, June 1991, Wiley

    Dr Günter Krause